[3H]Dopamine accumulation and release from striatal slices in young, mature and senescent rats

Aging and sex differences in striatal dopaminergic function

In this report the potassium- (30 mM) and amphetamine- (10 microM) stimulated responses of dopamine (DA) and 3,4-dihydroxy phenylacetic acid (DOPAC) from superfused striatal tissue of female and male mice as sampled at 2, 6, 18 and 24 months of age were compared. When assessed relative to responses obtained from 2-month-old female mice, potassium-stimulated DA output of female mice was significantly decreased at 18 months of age and significantly increased at 24 months of age. In male mice, the only statistically significant change was an increase in potassium-stimulated DA in the 24 versus 2-month-old mice. In response to amphetamine-stimulation, DA responses from striatal tissue of 18-month-old females were significantly decreased and that of 24-month-old mice significantly increased relative to that of the 2-month-old females. In the case of male mice, amphetamine-stimulated DA responses of 6- and 18-month-old mice were significantly decreased compared with responses observed in the 2-month-old males. In addition, amphetamine-stimulated DA responses of the 24-month-old females were significantly greater than the 24-month-old males. In general, the response profiles for DOPAC to potassium and amphetamine stimulation were similar to that of DA for male, but not female, mice. These results demonstrate that sex differences in striatal dopaminergic function are differentially affected by age. Overall, striatal DA responsiveness of female mice shows more extreme age-related changes, particularly between the 2- and 6-month versus the 18- and 24-month-old mice and a discord between DA and DOPAC responses. Such extreme changes may be related to the presence (at 2 and 6 months) versus absence (at 18 and 24 months) of estrous cycles/gonadal steroid hormonal functions in female mice.

Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique

To elucidate the mechanism of in vivo binding competition between radioligand and endogenously released transmitter, we examined the influence of depolarization-induced dopamine (DA) release on [11C]raclopride-specific binding to D2 receptors in slices of living brain tissues using dynamic positron autoradiography. Rat brain slices were incubated in a chamber with [11C]raclopride in oxygenated medium at 34 degrees C for 150 min. Two-dimensional images of radioactivity in the slices were recorded on a storage phosphor screen and dynamic changes were measured. When the brain slices were exposed to the depolarization agents (25 mM K+, 50 mM K+, and 20 microM veratridine), the percentage inhibition of striatal [11C]raclopride-specific binding was 22 +/- 4%, 44 +/- 8% and 54 +/- 7% of the control, respectively. The percentage inhibition of [11C]raclopride-specific binding during each depolarization treatment agreed proportionally with the amount of DA released into the medium. However, preexposure of brain slices to the same depolarization treatment (50 mM K+) did not affect the [11C]raclopride-specific binding, suggesting that the reduction in receptor density and/or affinity was not involved in the decrease of [11C]raclopride-specific binding. [11C]Raclopride-specific binding decreased dose-dependently in the presence of exogenously added DA (range 0.005-3mM). The synaptic DA concentration during each depolarization treatment estimated using three different methods. These results suggest that the decrease of [11C]raclopride-specific binding to striatal slices following evoked DA release is due to competition between endogenous DA and raclopride. It is unlikely that changes in D(2) receptor density or in affinity of the receptors for raclopride are involved. These results provide supportive evidence for in vivo binding competition between radioligand and endogenous neurotransmitter.

Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms

Age-related changes in both pre- and post-synaptic components of dopamine neurons have been demonstrated in humans as well as in animals. Our study was designed to examine the effects of age on presynaptic DA neurons. To assess the developmental changes in rat striatal dopamine carrier, we used [3H]GBR 12935, which binds selectively to this transporter. In addition we monitored changes in amphetamine- and KCl-induced [3H]DA release from rat striatal slices. We were able to demonstrate age dependent changes in DA transporter density, which reached a peak at age 3 months. Amphetamine-induced released of stored DA was exactly reversed, with a nadir at age 3 months. We assumed that the combination of low DA transporter level with increased transporter-mediated DA release may have a major compensatory role with respect to the maintenance of dopaminergic transmission during normal development, aging and neuro-degenerative diseases.

Age-related changes in rat brain monoamines release: peculiarity of dopamine release

Our aim has been to investigate the ability of the rat brain to retain its level of neurotransmitter release over life. We have investigated the neurotransmitter release from the rat brain synaptosomes prelabeled with 3H-DA, 3H-NA, or 3H-5HT, and perfused with Krebs-Ringer medium alone (basal release) or containing a high K+, calcium ionophore, tyramine or amphetamine (evoked release). Brain areas have been dissected of animals 45 days and 4, 6, and 11 months old. The results have shown a gradual reduction of the 3H-NA release evoked by a high K+ from 45 days to 6 months, which is stabilized until 11 months of age. The reduction rate has been relatively different from the brain areas investigated (36% for the frontal cortex and 26% for the hippocampus and cerebellar cortex). A similar reduction has been seen with 3H-5HT released from synaptosomes of the frontal cortex, hippocampus, and striatum. Surprisingly, the 3H-DA release that was evoked by high K+ was greater in rats 11 months old than in younger rats; this effect has been seen in synaptosomes from the caudate and the frontal cortex. The calcium ionophore A23187 has shown a releasing picture similar to a high K+. When we analyzed a nonexocitotic, but probably carrier mediated, release (evoked by tyramine or amphetamine), there was reduced release of all of the above neurotransmitters from 45 days to 11 months of age. We presume that there have been adaptive changes in neurotransmitter evoked release due to changes in Ca++ utilization, as inferred from the results from calcium ionophore experiments and carrier performance.(ABSTRACT TRUNCATED AT 250 WORDS)

Preservation of the density of the dopamine uptake complex in aging Fischer 344 rat brain

This study was performed to determine if there are selective regional or global changes in the density or pharmacology of the dopamine uptake complex (DAUC) in aged rodent. Fifteen regions of the Fischer 344 rat (aged 4, 12, and 24 months) central nervous system were analyzed for the density of the DAUC employing [3H]GBR 12935 and in vitro quantitative autoradiography. Additionally, cocaine competitions were performed in the striatum of all of the animals. A 26-fold variation in the DAUC density was found in the regions sampled. However, no significant age-related changes were identified. Intrastriatal analysis of the DAUC density revealed binding heterogeneities; decreasing lateral to medial and decreasing dorsal to ventral gradients. No significant effect of aging on striatal gradients was observed. The proportion of high and low affinity sites for cocaine was unchanged in the three age groups. Taken together, these findings suggest a stability of this dopamine presynaptic marker in aging rat central nervous system.

N-methyl-D-aspartate mediated responses decrease with age in Fischer 344 rat brain

N-Methyl-D-aspartate (NMDA) receptor-mediated responses were studied in hippocampus, cortex, and striatum of Fischer 344 rats of various ages (3-5, 12-14, or 24-28 months old; young, middle-aged, and senescent or old, respectively) to determine whether aging alters the function of NMDA receptors. NMDA-induced inhibition of muscarinic-stimulated phosphoinositide hydrolysis in hippocampus, and NMDA-stimulated release of [3H]norepinephrine (NE) or [3H]dopamine (DA) were used as indices of NMDA receptor function. The muscarinic agonist carbachol (1 mM) stimulated PI hydrolysis in hippocampi from all three age groups with no significant differences between the groups. NMDA inhibited the carbachol-evoked PI response in a concentration-dependent manner (10-100 microM) in all age groups. However, the NMDA-induced (100 microM) inhibition of the carbachol-stimulated response was markedly reduced in an age-dependent manner with losses of 25% and 53% in middle-aged and senescent rats compared to young. Concentration-effect curves for NMDA-stimulated [3H]NE release were determined using hippocampal and cortical slices from rats of the three age groups. In the hippocampus the maximal response for NMDA was significantly decreased from 6.55 fractional [3H]NE release in young to 4.51 and 4.18 in middle-aged and old rats, respectively, with no age-related changes in the potency of NMDA or slope of the curves. In cortical slices the maximal response was significantly reduced in an age-dependent manner by 23% in the senescent rats compared to the young rats. NMDA-stimulated [3H]DA release from striatal slices was significantly lower in the senescent rats at concentrations of NMDA from 500-2000 microM.(ABSTRACT TRUNCATED AT 250 WORDS)

Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine

In the present experiments we examined the effects of two different modes of infusion (two separate 10 min versus continuous infusions) of a depolarizing concentration of potassium (K+, 30 mM), amphetamine (AMPH, 10 microM), or L-DOPA (5 microM) upon dopamine (DA) release in vitro from superfused corpus striatal (CS) tissue fragments of young (2-4 months) and aged (18-24 months) male rats. The relative changes in DA release to two infusions of K+ and AMPH (R2/R1) were virtually identical for CS from both young and aged rats. In the case of L-DOPA, DA release from CS of young rats was markedly increased in response to the second compared to the first L-DOPA infusion (R2/R1 = 2.48 +/- 0.33, N = 7) and significantly greater than that of aged rats (R2/R1 = 1.24 +/- 0.17, N = 6). A continuous infusion of K+ and AMPH resulted in an overall greater amount of DA release from the CS of young versus aged rats. In contrast, DA release from CS of aged rats showed an overall more rapid and greater amount of DA release to continuous L-DOPA infusion than that from the CS of young rats. These results demonstrate age-dependent differences in DA release from the CS as a function of the infusion mode of specific secretagogues. Particularly interesting were the responses to L-DOPA where a pulsatile administration resulted in an overall greater amount of DA release from the CS of young rats while a continuous infusion produced a greater amount of DA release from the CS of aged rats.

Age-related decline in rat striatal dopamine metabolism is regionally homogeneous

Previous research has established that the age-related decrease in rat striatal D2 sites occurs predominantly in the posterior ventral caudate-putamen, and the present work was undertaken to determine whether a corresponding preferential reduction in dopamine, its metabolites, or its synthesis rate occurs in this region. Male F344 rats 4-8 or 25-27 months old were used for regional HPLC electrochemical determinations of 1) dopamine, homovanillic acid (HVA), or dihydroxyphenylacetic acid (DOPAC) obtained from striatal micropunch samples, or 2) 3,4-dihydroxyphenylalanine (DOPA) concentrations in these same micropunch regions 30 minutes after treatment with the aromatic amino decarboxylase inhibitor, NSD-1015 (100 mg/kg, IP). Aged rats had significantly less dopamine, HVA, and DOPAC in their striatal samples than did young adult controls, as well as having less DOPA accumulation after NSD-1015. However, for none of these measures was the age x region interaction significant, suggesting that the decline in these markers of presynaptic dopaminergic function occurs uniformly throughout the striatum. The results provide evidence that the effects of aging on striatal dopamine receptors are dissociable from the influences on the dopaminergic innervation of this structure, suggesting independent control of pre- and postsynaptic elements of these synapses during the lifespan.

The effect of L-dopa upon in vitro dopamine release from the corpus striatum of young and old male rats

In the present experiments, we examined the effects of superfusion of L-DOPA upon in vitro dopamine (DA) release from the corpus striatum (CS) in young (2-4 months) and old (24 months) male rats. In Experiment I, responses to two successive increasing doses of L-DOPA (1.0 and 10 microM) indicated a clear age difference with DA release from CS of young rats significantly greater than that of old rats in response to the 10 microM dose of L-DOPA. Interestingly, CS fragments of young and old male rats responded marginally to the 1.0 microM L-DOPA infusion, and no significant differences between these two age groups were obtained. Since we have previously observed that the addition of naloxone to the superfusion medium restored the potassium stimulated DA release of old rats to that of young rats, in Experiment II, responses of CS tissue fragments of young and old rats superfused in medium with or without naloxone (100 microM) were tested with a single 10 microM L-DOPA infusion. The results of Experiment II indicated that the addition of naloxone to the superfusion medium did not alter the responses of CS tissue to L-DOPA in either young or old rats; however, the overall response of the young rats remained significantly greater than that of the old rats. Taken together, these results demonstrate a significant age-related decrement in the capacity of 10 microM L-DOPA to stimulate DA release from CS fragments.(ABSTRACT TRUNCATED AT 250 WORDS)

Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry

Fast cyclic voltammetry at carbon fibre microelectrodes was used to measure electrically stimulated dopamine release in the striatum of anaesthetised young, adult, and senescent Wistar rats. By alteration of stimulus parameters and by use of nomifensine, investigation of dopamine release, uptake, and compartmentalisation within the striatum was possible. The rate of dopamine release was highest in adult rats. No difference was observed between young and old animals. The size of the releasable (newly synthesised) dopamine pool was also largest in the adult group, again with no significant difference occurring between young and aged rats. The rate of dopamine uptake was highest in adult rats, although, when expressed as a function of dopamine release, young and aged rats showed proportionally greater uptake. Nomifensine (10 mg/kg i.p.) increased dopamine release by mobilising the inert storage pool to a greater extent in young than in adult rats, whereas the effect of the drug on uptake was similar in all age groups. The functional significance and possible explanation of these results are discussed.

Aging does not alter the voltage-dependent release of endogenous dopamine from mouse striatal synaptosomes

Striatal synaptosomes isolated from 3-, 12-, and 24-month-old C57B1/6J mice were exposed to low (5 mM) and high (30 mM) concentrations of potassium of 1, 3, 5, 15 and 30 s. There were no age-related differences in the total intrasynaptosomal content of dopamine among the three age groups of mice. The basal release of endogenous dopamine from synaptosomes isolated from 24-month-old animals was significantly greater than that from synaptosomes isolated from 3-month-old animals at all time points tested. Similarly the potassium stimulated release of dopamine from 24-month-old animals was also higher than that from the 3-month-old group, but this increase was not statistically significant. The net voltage-dependent release of dopamine (stimulated minus basal) was similar for all groups at all time points measured. The increase in basal dopamine release in the 24-month-old animals may reflect an increased fragility or leakiness of the synaptosomal preparation.

Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence

Previous experiments have indicated that the release of striatal dopamine (DA) is controlled by inhibitory DA autoreceptors which are mediated by inhibitory cholinergic heteroreceptors (HTRs). Activation of the HTRs by muscarinic or nicotine agonists potentiates the K+-evoked release of DA from the striatum. Present experiments were carried out to determine if this relationship is altered as a function of aging. Cross-cut striatal tissue slices obtained from 3 age-groups (6, 12-18 and 24 months) Wistar rats were superfused with a modified Krebs-Ringer basal release medium containing 2.5 mM KCl. After a 30-min equilibration period, a 5-min baseline fraction was collected from each chamber. The medium was then switched to one containing 30 mM KCl, and depending upon the experiment, 1 of 4 concentrations of a particular muscarinic (oxotremorine, pilocarpine, carbachol or bethanecol) or nicotinic (nicotine) agonist. In some experiments DA autoreceptor function was assessed directly with haloperidol. Six 5-min fractions were taken during depolarization. DA release was assessed using high performance liquid chromatography coupled to electrochemical detection. Results indicated that the efficacy of the muscarinic agonists was reduced in an age-dependent manner with the oldest age groups showing the smallest enhancement. The age at which the decline was seen was dependent on the muscarinic agonist that was applied. Deficits were seen as early as 12 months when full agonists (e.g. carbachol) were applied, but did not appear until 18 months when partial agonists (e.g. oxotremorine) were applied. These age-related alterations were not seen when haloperidol or nicotine were used to enhance the K+-evoked release of DA.(ABSTRACT TRUNCATED AT 250 WORDS)

Release of 3H-dopamine and analogous monoamines from rat striatal tissue

1. The release of previously accumulated 3H-dopamine (DA) from minces of striatal tissue prepared from the brains of pargyline-pretreated rats was evaluated by superfusion with a physiological buffer solution in a six-chamber apparatus with silver toroid electrodes to provide electrical field stimuli. The identity of released tritium as 3H-DA was demonstrated chromatographically and 3H-DA taken up was found in a synaptosomal subcellular fraction. 2. Release of 3H-DA previously accumulated at 0.3 microM was found to be linearly dependent on stimulus intensity between 1 and 10 V (for 60 sec); 5 V was selected as a standard stimulus. 3. Release of 3H-DA did not occur from minces of rat liver, nor was there release of previously accumulated labeled urea or leucine from striatal tissue by electrical stimulation, 50 mM KCL, or 0.1 mM (+)-amphetamine. When 3H-DA was taken up in the presence of cocaine (1 mM) or benztropine (100 microM), electrically induced release of 3H-DA was markedly reduced, while spontaneous efflux was much less altered. 4. Release of 3H-DA was also induced by depolarizing concentrations of K+, as well as by Rb+ or NH4+, and by veratridine. Electrical release and that induced by 50 mM K+ or 100 microM veratridine was blocked by the omission of Ca2+ (with EDTA added) and that induced by veratridine was blocked by tetrodotoxin (30 microM).

The importance of striatal interneurons in age-related effects upon potassium- and amphetamine-stimulated dopamine release

The ability of superfused corpus striatal tissue fragments to release endogenous dopamine (DA) in response to potassium (K+ 30 mM) stimulation was significantly attenuated in 18- to 24-month- compared to 2- to 4-month-old male rats. These age-related effects on K+ stimulation were completely abolished with the addition of tetrodotoxin (1 microM) to the superfusion medium. Moreover, no difference in stimulated DA release was obtained between these two age groups following amphetamine stimulation (10 microM).

Regionally selective manifestations of neostriatal aging

Presynaptic and postsynaptic markers of the cholinergic and dopaminergic systems have characteristic topographical distributions within the striatum. Aside from the dopaminergic afferents, several other afferent systems exhibit a heterogeneous distribution in the striatum. The net result is that each part of the striatum receives a specific and unique combination of afferents. Moreover, the intrinsic striatal systems also have unique distributions, so each part of the striatum consists of a unique combination of afferent and intrinsic neurotransmitter systems. In view of these points, one may expect that the striatum is functionally very complex, integrating information from a wide variety of brain areas. One may also assume from these facts that the striatum is a functionally heterogeneous structure. Consistent with that conclusion, behavioral and pharmacological studies show that interruption of neurotransmission in localized regions of the striatum produces very specific behavioral and physiological effects. Age-related neurochemical changes are also confined to specific striatal regions. Which regions are affected will depend on a variety of factors, including the neurochemical parameter studied and the species or strain of animal. However, we still do not know what factors make a particular striatal area vulnerable to the effects of aging or disease. Moreover, a question that remains to be answered is whether the regions that are affected by neurodegenerative diseases are the same ones affected during normal aging. If so, then this may provide a clue as to why neurodegenerative diseases of the basal ganglia increase in frequency with advancing age. Nevertheless, discrete regional neurochemical alterations may underlie specific symptoms of these diseases. Further study of this relationship may provide the basis for treatments that better target the source of the symptoms. Not only would this increase the effectiveness of the treatment, it would help reduce potential side effects. This may be particularly important, for example, with respect to the use of tissue explants in the treatment of diseases of the basal ganglia.

Influence of aging on catecholamine levels, accumulation, and release in F-344 rats

Neuronal function in selected brain areas has been evaluated in Fischer 344 rats aged 2-4 months, 11-14 months and 21-26 months. In vitro release of 3H-norepinephrine from hypothalamus and occipital cortex and 3H-dopamine from striatum has been evaluated using potassium, amphetamine, and field-stimulation. In vitro uptake of 3H-catecholamines has been evaluated in the same tissues. Catecholamine levels were measured in six brain areas: hypothalamus, striatum, cortex, cerebellum, brainstem and midbrain. Significant age-related decreases of NE levels, uptake, and release to high frequency stimulation were seen in the hypothalamus. The decreases in 3H-NE uptake and NE levels in the hypothalamus were apparent at 12 months, whereas the decrease in 3H-NE release after high frequency stimulation was seen in the senile rats.

Age-related reductions in brain cholinergic and dopaminergic indices in two rat strains differing in longevity

We have recently reported that inbred Wistar-Kyoto rats which are highly reactive to stressful stimuli, have a much shorter mean life-span (21.5) compared to the less reactive Brown-Norway rats (31.0 +/- 4.5 months). In the present study we found a reduction in forebrain cholinergic neurotransmission indices in 24-month-old Wistar-Kyotos but not in Brown-Norways as compared to their respective young (3-month-old) counterparts. Also only in Wistar-Kyotos dopamine uptake was reduced in the aged striatum, but in the septum it remained unchanged in both strains. In Brown-Norways, age-related changes were observed only in choline acetyltransferase activity and only in brain regions known to contain mainly cholinergic nerve cell bodies. We conclude that at 24 months of age, reductions in brain cholinergic and dopaminergic neurotransmission are more prominent in the highly stress-reactive and shorter-lived Wistar-Kyoto strain, and may be genetically determined.

Selective alteration of mouse brain neurotransmitter release with age

The release of acetylcholine (ACh), glutamate (GLU) and dopamine (DA) from various brain regions was investigated in young (3 month) and old (30 month) Balb/c mice. Aging increased the basal release of GLU (77%) and DA (29%) in striatum and GLU in hippocampus (94%); the concentrations of these neurotransmitters in the media after K+ stimulation were unaltered by aging. Although the basal release of ACh was not altered by age, K+-stimulated ACh release was reduced in striatum. The age-related increases in basal GLU and DA release may be important in the pathophysiology of cell death during aging.

Striatal dopamine uptake and swim performance of the aged rat

The striatum and olfactory tubercle of 30-month-old F344 rats contain significantly (21-24%) less dopamine compared with young adult (8-month) animals. However, rats of the two age groups show identical Km and Vmax values for the kinetics of [3H]dopamine uptake into striatal homogenates; uptake into the olfactory tubercle also appeared unaffected in old age. The preservation of dopamine uptake despite reductions in content of the transmitter suggests that the forebrain dopaminergic nerve terminals are intact, but that reduced dopamine synthesis and/or enhanced degradation may occur in the existing terminals. Administration to senescent animals of the dopamine uptake blockers nomifensine or bupropion (but not the norepinephrine uptake blocker desmethylimipramine) improved their swim performance to levels comparable with young adult animals. The findings suggest that amine reuptake may limit the synaptic effectiveness of dopamine released in the aged striatum.

Age-related alterations in monoamine release from rat striatum: an in vivo electrochemical study

In vivo electrochemistry was used to examine presynaptic alterations in dopamine release in the striatum of aged rats. Chronoamperometric determinations of monoamine release, induced by local micro pressure-ejection of K+, were made using Nafion-coated graphite epoxy electrodes. Recordings were made from the striatum of urethane-anesthetized Fischer 344 rats at 6, 24, and greater than or equal to 29 months of age. Following the in vivo electrochemical experiments, the animals were sacrificed and the caudate nucleus removed for analysis of whole tissue levels of monoamines and their metabolites using standard HPLC techniques. Overall, mean amplitudes of K+-evoked releases from the striatum of 6 month and 24 month F344 rats did not differ significantly (p greater than 0.1). However, this result was complicated by the observation that the mean values obtained from two separate groups of 24 month animals, recorded 6 months apart, were significantly different from each other (p less than 0.001). Mean releases for the later 24 month group were significantly less than for the 6 month group (p less than 0.01). No difference was found in the release magnitudes of 6 month animals recorded contemporaneously with the two groups of 24 month rats. Release amplitudes for the greater than or equal to 29 month group were clearly less than from the 6 month animals (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Brain dopamine autoreceptors in aging rats

The function of dopamine (DA) autoreceptors is evaluated in vivo in striatum and mesolimbic regions of young adult (4 months), mature (14 months) and old (26 months) male Wistar rats. gamma-Butyrolactone (GBL)-induced dihydroxyphenylalanine (DOPA) accumulation in rats also treated with an inhibitor of aromatic L-aminoacid decarboxylase was used to determine the presence of synthesis-modulating nerve terminal autoreceptors while its reversal with apomorphine served as an index of autoreceptor stimulation. GBL-induced DOPA accumulation in striatum is very high at all three ages (130-150% increase in comparison with controls) as is its reversal by apomorphine (65-80% decrease in comparison with GBL alone). In mesolimbic regions, GBL has much less effect than in striatum (31% rise at 4 and 26 months, 12% rise at 14 months), but apomorphine's effect is of the same order of magnitude (down 60-80%). The conclusion can be drawn that aging does not significantly affect DA autoreceptor function in striatum and mesolimbic areas.

High-affinity uptake of neurotransmitters in rat neostriatum: effects of aging

High-affinity uptake of dopamine (DA), glutamate, and gamma-aminobutyric acid (GABA) was determined in crude synaptosomal preparations from neostriatal regions of rats 7, 17, and 27 months of age. Dopamine uptake was highest in rostral neostriatum, but no age-related differences were detected. On the other hand, the high-affinity uptake of both GABA and glutamate was increased with age. This may reflect astrocytic hypertrophy or hyperplasia, which have been reported to occur in the neostriatum during the aging process.

Release of endogenous dopamine from electrically stimulated slices of rat striatum

An experimental system is described for measuring the release of endogenous dopamine from electrically stimulated slices of rat striatum. Striatal slices were field-stimulated by two high frequency trains (S1 and S2) applied 10, 30 or 60 min apart. The quantities of dopamine released by the two stimuli were compared from slices incubated with and without dopamine's precursor, L-tyrosine. Sustained release of dopamine evoked by the two stimuli was shown to require the inclusion of tyrosine (50 microM) in the superfusate.

Age-related decrease in apomorphine modulation of acetylcholine release from rat striatal slices

Release of [3H]acetylcholine ( [3H]ACh) was assessed in striatal slices from mature, middle-aged and senescent Wistar rats 8, 12 and 24 months of age, respectively. There was an age-related decline in basal release of [3H]ACh as a function of age which was correlated with a decline in accumulation of [3H]ACh. However, the most striking finding was the failure of apomorphine to inhibit KCl-induced [3H]ACh release in the senescent (24 months) animals. Striatal dopaminergic receptor losses in senescence apparently produce several subsequent changes in striatal function which ultimately result in the decline of motor-behavioral function.